Earnest Partners Llc
Source: SEC Form 13F · as of Mar 2026Earnest Partners Llc holds 10 biotech & pharma companies tracked by BioSniper, totaling $721.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
10
Total value held
$721.4M
BioSniper AIPage evidence connected
Prepared research question
What matters most for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 971,366 | $167.6M |
| QGENQIAGEN N.V. | 3,868,489 | $154.9M |
| NVSNovartis AG | 885,290 | $135.2M |
| ICLRICON plc | 885,790 | $98.0M |
| IQVIQVIA Holdings Inc. | 534,647 | $91.2M |
| CORCencora Inc. | 227,554 | $71.5M |
| ELVElevance Health Inc. | 5,529 | $1.6M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 3,035 | $821K |
| LLYELI LILLY & Co | 399 | $367K |
| JNJJOHNSON & JOHNSON | 888 | $217K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.